CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

• Responsible AI In Clinical Trials Starts With How It Is Designed

  Explore how trials can responsibly use AI to move faster while keeping human judgment, data protections, and auditability intact.

• Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us

  Benchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.

• Expression Of Key Immunology Drug Targets In Human Inflammatory Challenge Models

  Human challenge models reveal immune pathway behavior in controlled settings, linking early research to outcomes and helping confirm target engagement, refine dosing, and reduce development uncertainty.

• Data Quality And Monitoring In Clinical Trials: Reducing Errors And Ensuring Compliance

  Clear data ownership and tailored reporting tools reduce errors and manual reconciliation, keeping trial data accurate and audit-ready.

• CRF Validation Best Practices: Building Reliable Clinical Trial Databases

  CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.